Advertisement
Screener

VITASPRING BIOMEDICAL CO., LTD. (VSBC) Increase (Decrease) in Inventories

2.8 / 5 stars · 68/120 Roast Me

VITASPRING BIOMEDICAL CO., LTD. Increase (Decrease) in Inventories

VITASPRING BIOMEDICAL CO., LTD. (VSBC) reported Increase (Decrease) in Inventories of $0 for the 12-month period ending 2023-01-31, per its 10-K filed 2025-12-01.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2025-12-01

  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for the quarter ending 2022-01-31 was -$288.00K.
  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for the quarter ending 2021-10-31 was $0.00.
  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for the quarter ending 2021-07-31 was $0.00.
  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for the quarter ending 2021-04-30 was $144.00K.
  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for fiscal 2023 was $0.00.
  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for fiscal 2022 was -$144.00K, a 200.00% decline from fiscal 2021.
  • VITASPRING BIOMEDICAL CO., LTD. increase (decrease) in inventories for fiscal 2021 was $144.00K.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2023-01-31$0.00
10-K · filed 2025-12-01
2022-01-31-$288.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-01
-$288.00K
derived: sum of 2 quarters · filed 2025-12-01
-$288.00K
derived: sum of 3 quarters · filed 2025-12-01
-$144.00K
10-K · filed 2025-12-01
2021-10-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-21
$0.00
derived: sum of 2 quarters · filed 2022-12-21
$144.00K
10-Q · filed 2022-12-21
2021-07-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-09-15
$144.00K
10-Q · filed 2022-09-15
2021-04-30$144.00K
10-Q · filed 2022-06-15
2021-01-31$144.00K
10-K · filed 2022-05-03